Compare FCEL & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCEL | INSP |
|---|---|---|
| Founded | 1969 | 2007 |
| Country | United States | United States |
| Employees | 629 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2018 |
| Metric | FCEL | INSP |
|---|---|---|
| Price | $21.37 | $51.03 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $8.31 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 12.3M | 867.5K |
| Earning Date | 06-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $4.77 | $8.02 |
| Revenue Next Year | $42.46 | $8.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $3.78 | $38.91 |
| 52 Week High | $37.88 | $147.03 |
| Indicator | FCEL | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.84 | 56.94 |
| Support Level | $16.66 | $48.30 |
| Resistance Level | $27.69 | $58.45 |
| Average True Range (ATR) | 2.45 | 2.26 |
| MACD | -0.22 | -0.17 |
| Stochastic Oscillator | 56.23 | 63.45 |
FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.